Experiment summary for ENCSR379NMT
doi:10.17989/ENCSR379NMT
Summary
- Status
- released
- Assay
- ATAC-seq
- Biosample summary
- Homo sapiens stimulated activated naive B cell male adult (40 years) treated with 1 μg/mL anti-CD40 for 72 hours, 10 μg/mL anti-IgM for 72 hours, 100 ng/mL Interleukin-4 for 72 hours
- Biosample Type
- primary cell
- Replication type
- isogenic
- Treatments
- 1 μg/mL anti-CD40 for 72 hours, 10 μg/mL anti-IgM for 72 hours, 100 ng/mL Interleukin-4 (UniProtKB:P05112) for 72 hours
- Nucleic acid type
- DNA
- Size range
- 150-1000
- Fragmentation methods
- chemical (Tn5 transposase)
- Platform
- Illumina NovaSeq 6000
Attribution
ENCODE4 project
- Lab
- Michael Snyder, Stanford
- Award
- UM1HG009442 (Michael Snyder, Stanford)
- Project
- ENCODE
- External resources
- Aliases
- michael-snyder:pAS-590, michael-snyder:pAS-h.CD19 Naive 72 hour BCR avtivation (Altius Donor 10)
- Date submitted
- August 25, 2021
- Date released
- September 9, 2021
- Annotation (ChromBPNet-model)
- Tags
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Library |
|---|---|---|---|---|
| 1 | 1 | Homo sapiens male adult (40 years) stimulated activated naive B primary cell treated with 1 μg/mL anti-CD40 for 72 hours, 10 μg/mL anti-IgM for 72 hours, 100 ng/mL Interleukin-4 for 72 hours | ENCBS737YXU | ENCLB380ZTT |
| 2 | 1 | Homo sapiens male adult (40 years) stimulated activated naive B primary cell treated with 1 μg/mL anti-CD40 for 72 hours, 10 μg/mL anti-IgM for 72 hours, 100 ng/mL Interleukin-4 for 72 hours | ENCBS012FWY | ENCLB088FAZ |